New generic medications are now available for the brand-name medications listed below. If you prescribe any of these brand-name medications to HealthChoice members, please note that the generic medication saves them money at the pharmacy. This applies to all HealthChoice members, including all members of the HealthChoice Medicare Supplement Plans With and Without Part D.
| Brand-Name Medication | Generic Medication | Treatment | Launch Date |
|---|---|---|---|
| Actos® | pioglitazone hydrochloride | Type 2 Diabetes | Aug-12 |
| Actoplus Met® | pioglitazone hydrochloride and metformin hydrochloride | Type 2 Diabetes | Aug-12 |
| Arthrotec® | diclofenac sodium and misoprostol | Pain and joint stiffness associated with Arthritis | Nov-12 |
| Avalide® | irbesartan/hydrochlorothiazide | High blood pressure | Apr-12 |
| Avapro® | irbesartan | High blood pressure | Apr-12 |
| Boniva® | ibandronate sodium | Osteoporosis | Mar-12 |
| Detrol® | tolterodine tartrate | Overactive bladder | Aug-12 |
| Diovan® | valsartan | High blood pressure | Sep-12 |
| Diovan HCT® | valsartan and hydrochlorothiazide | High blood pressure | Sep-12 |
| Geodon® | ziprasidone hydrochloride | Bipolar/Schizophrenia | Mar-12 |
| Lescol® | fluvastatin capsules | hypercholesterolemia | Apr-12 |
| Lexapro® | escitalopram oxalate | Anxiety and Depression | Feb-12 |
| Maxalt® | rizatriptan | Migraines | Jan-13 |
| Maxalt-MLT® | rizatriptan | Migraines | Jan-13 |
| Plavix® | clopidogrel tablets | Acute coronary syndrome | May-12 |
| Prometrium® | progesterone | Hormone replacement | Mar-12 |
| Provigil® | modafinil | Narcolepsy | Mar-12 |
| Seroquel® | quetiapine | Major depressive disorder | Apr-12 |
| Singulair® | Montelukast | Asthma and Hayfever | Aug-12 |
| Soma® 250mg | carisoprodol | Muscle injuries | Dec-10 |
| Xopenex® Inhaled Solution, 0.31mg/3ml, 0.63/ 3ml, 1.25mg/3ml | levalbuterol HCl | Bronchospasm in adults, adolescents, and children 6 years of age and older | Aug-12 |
Please Note: The launch dates listed above are subject to change based on new or ongoing legal issues between the brand and generic manufacturers.